Humacyte falls after wider-than-expected quarterly loss
12/08/2026 15:17
BUZZ-Humacyte falls after wider-than-expected quarterly loss ** Shares of biotech firm Humacyte HUMA.O fall 10% to 63 cents
** Co posts Q2 loss of 16 cents per share, wider than analysts' estimate for a loss of 1 cent per share - LSEG data
** Reports Q2 revenue of $406,000, below estimates of $1.12 million
** BTIG says, "We continue to believe shares can move higher as milestones are achieved and the commercial ramp builds, but acknowledge that near-term revenue visibility remains limited."
** HUMA reports cash, cash equivalents and restricted cash of $80.3 million as of June 30
** As of last close, stock down 35.3% YTD
(Reporting by Siddhi Mahatole)
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary